Evidence map›Paper›PMID 25099099›Full record

ReviewContinuum (Minneapolis, Minn.)2014

Metabolic, hereditary, traumatic, and neoplastic optic neuropathies.

Gregory P Van Stavern

Erratum issued Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Continuum (Minneapolis, Minn.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04942002 (Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis. Randomized Controlled Trial.), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04942002 phase2 / phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis. Randomized Controlled Trial.

TypeinterventionalSponsorAsociación para Evitar la Ceguera en MéxicoRan2021 to 2023Enrolled50ConditionsOptic Neuritis, Treatment, MethylprednisoloneArmsMethylprednisolone Acetate 40 MG/ML [Depo-Medrol], Placebo Comparator: Standard treatment + placebo
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Salvaging Vision: A Study of Non-Traumatic Optic Neuropathies.Journal of rhinology : official journal of the Korean Rhinologic Society · 2024
    Article
  3. Article
  4. Review
  5. Oxidative Stress in Optic Neuropathies.Antioxidants (Basel, Switzerland) · 2021
    Review
  6. Review
  7. Article
  8. Antibiotic-induced neurotoxicity.Current infectious disease reports · 2014
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

1 author.

Gregory P Van Stavern

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewToxic, nutritional, hereditary, traumatic, and neoplastic optic neuropathies result in significant disability due to visual dysfunction. Many of these conditions are treatable. Early diagnosis may allow for intervention to stabilize or improve vision and prevent unnecessary testing. These conditions have overlapping clinical features, and careful assessment of the visual system allows for accurate diagnosis and management. RECENT

findingsNewer treatment strategies are available for optic neuropathies previously thought untreatable, such as some hereditary optic neuropathies. Many conditions that previously were felt to represent distinct diseases can be linked by a common pattern of mitochondrial dysfunction. SUMMARY: The optic nerve is susceptible to a wide variety of pathologic processes. The correct diagnosis depends on a thorough history and detailed evaluation of the visual system. Certain optic neuropathies selectively affect the papillomacular bundle, and particular attention to this location can considerably narrow the differential diagnosis and subsequent workup.

Indexed as

Optic Nerve DiseasesAdolescentAgedDeficiency DiseasesFemaleHumansMaleMetabolic DiseasesMiddle AgedNeurotoxicity Syndromes

Identifiers

PMID25099099
PMCPMC10563990
OpenAlexW2339561659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.